Trump parades recovered Covid-19 patients while attacking Biden and praising controversial coronavirus drug
After first downplaying severity of Covid-19, president tells recovered victims it’s a ‘plague’ and ‘scourge’
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Donald Trump, in a much more jovial mood than during a confrontational Monday evening press conference, used a meeting with recovered coronavirus patients to take a jab at Joe Biden and again advocate for a malaria medication in which his family reportedly has a financial stake.
The president joked with, and questioned, a handful of individuals who contracted the sometimes-deadly virus in a midday Cabinet Room meeting in which everyone was social distancing. But, as usual, Mr Trump used the event to suggest hydroxychloroquine can help most who get the virus recover faster – and he suggested the former vice president, the likely Democratic presidential nominee, would, if elected, block its mass production during a pandemic.
The meeting, which Mr Trump allowed to be witnessed by journalists, was vintage showman Trump. It also featured a lengthy discussion of NFL quarterback Tom Brady, and his chances with his new team in Tampa Bay, Florida.
“Say hello to Tom when you see him,” Mr Trump told Mark Campbell he called a friend of Mr Brady. “He’s a great guy.”
The president, as he often does, also reversed himself. This time, again, it was about the severity of coronavirus.
After spending much of January and February calling it similar to the flu and likely to dissipate when the weather warmed, on Tuesday he called it a “plague” and a “scourge,” saying “it’s rough, it’s bad”.
One of his guests in the ornate Cabinet Room was Karen Whitsett, a Democratic state legislator, who told him she became alarmed during her Covid-19 experience “by the breathing”. She and her husband told the president how they finally acquired a prescription for the malaria drug.
Before she was finished, Mr Trump said her “thank you” to him for pushing the medication shows she has a political future and he “might cross the political aisle” to work with her.
“I’m not going to speak for her, but I don’t see her voting for ‘Sleepy Joe‘ Biden,” Mr Trump said of Ms Whitsett. “If she votes for ‘Sleepy Joe,’ I’d be surprised.”
His comment was eyebrow-raising because the state representative never blamed any Democratic lawmaker, local or national, for her experience. She did call for hydroxychloroquine to be available more readily in Detroit, which has been hit hard by the pandemic.
But she never said or alluded to an opinion that any state, local or national Democratic official was blocking the drug.
“What do you have to lose? It’s an unbelievable malaria drug, an unbelievable lupus drug,” Mr Trump said, offering no medical or scientific evidence for his claims. “I haven’t heard a bad story.”
Some people, however, have taken the drug and experienced side effects.
Despite having downplayed the virus’s severity early on, Mr Trump, while seated with the victims called it a “bigger, better, much worse event” than the common flu.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments